The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Gene Expression Identifies Two Crohn’s Disease Subtypes

Gene Expression Identifies Two Crohn’s Disease Subtypes

October 21, 2016 • By Will Boggs, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Gene expression and chromatin accessibility can be used to identify two Crohn’s disease (CD) molecular subclasses that match distinct disease phenotypes, researchers report.

You Might Also Like
  • Gene Expression Markers in T Cells Help Identify SLE Patient Subtypes
  • Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes
  • Gene Expression Signature Useful for Diagnosing Kawasaki Disease

“The hope one day is to be able to test Crohn’s patients for the subtype of the disease they have, and thus determine which treatment should work best,” Dr. Shehzad Z. Sheikh from the University of North Carolina at Chapel Hill tells Reuters Health by email. “The idea is to find the best therapeutic course for each patient as quickly and efficiently as possible.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Molecular subtypes defined by gene expression have been documented in other complex diseases. But it remains largely unknown whether molecular classes can explain the heterogeneous phenotypes seen in CD, Dr. Sheikh and colleagues explain in Gut, online Oct. 14.1

To investigate, the team examined gene expression and chromatin accessibility in unaffected colon mucosa from 21 patients with CD and 11 patients with non-inflammatory bowel disease (non-IBD).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

They used principal components analysis (PCA) to identify two distinct, expression-based subclasses of individuals with CD, one of which clustered with the non-IBD controls.

Most of the top 25 differentially expressed genes had tissue-specific expression patterns that discriminated colon from small intestine (ileum), according to the Oct. 14 online report.

CD samples similar to non-IBD controls expressed colon-specific genes, whereas samples from the other CD subclass showed expression patterns more consistent with ileum despite being sampled from the colon.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Chromatin accessibility data suggested that these subclasses exist due to stable molecular transformations of the genomic architecture in colon tissue cells and not due to transient differences resulting from external cellular signaling.

Samples from ileal biopsies of treatment-naïve pediatric CD patients revealed a similar pattern, suggesting that the colon-like and ileum-like molecular signatures define two forms of CD regardless of tissue sampling location, patient age, or treatment status.

The gene expression profiles also revealed differences in lipid metabolism and metabolism of foreign agents between the two subclasses.

The molecular subclasses were associated with clinical outcomes. Patients with colon-like CD displayed both colon and ileum involvement, had deep ulcers, and showed macroscopic inflammation, while patients with ileum-like CD were less likely to show inflammation and more likely to have colon-only involvement.

“As an initial follow-up and to confirm our findings in a much larger set of patient samples, we were recently funded by the National Institutes of Health,” Dr. Sheikh says. “With this long-term study we would test patients for their Crohn’s subtype when they are initially diagnosed with the disease, and then follow them for several years to see whether the assigned subtype predicts the disease course. Furthermore, we are exploring these molecular markers in serum to allow for practical application at the patient’s bedside.”

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: Crohn's disease, gene, genetic risk

You Might Also Like:
  • Gene Expression Markers in T Cells Help Identify SLE Patient Subtypes
  • Synovial Analysis Identifies Distinct Rheumatoid Arthritis Subtypes
  • Gene Expression Signature Useful for Diagnosing Kawasaki Disease
  • Study Finds Correlations Between Synovial Tissue & Gene Expression

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.